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Edited by Jesus AvilaAbstract Recent studies have led us to suppose that synergistic
action of multiple solute cofactors could play substantial roles in
amyloid-type ﬁbrillogenesis of pathogenic polypeptides. To sup-
port this view, we performed aggregation experiments of human
islet amyloid polypeptide (IAPP) in media containing both
polyanions and non-polar solvents. The results demonstrated that
the ﬁbrillation at sub-micromolar IAPP occurred only when
polyanionic and non-polar solutes coexist. A simple sum of two
independent cofactor’s eﬀects could not account for the synergis-
tic action. We propose that this synergy of polyanionic and non-
polar milieus could substantially modify the amyloidgenesis in
the human body.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Progressive formation of proteinaceous inclusions in brains
and peripherals is a hallmark lesion of human degenerative dis-
eases [1,2]. The amyloid-type aggregation of ﬁbrillogenic poly-
peptides including b-peptide of Alzheimer’s disease and islet
amyloid polypeptide (IAPP) of type 2 diabetes has been related
to pathological events responsible for cell death and organ dys-
functions [1–3]. Previous in vitro studies have elucidated
molecular details of the ﬁbrillation mechanism and the ﬁbril
structures [4–6], but the events occurring in the living body
are largely unresolved.
Physiological concentrations of amyloidgenic proteins are
lower than the critical lower limit concentrations of the ﬁbril-
lation in vitro. To explain this discrepancy, previous studies
have identiﬁed a variety of ﬁbrillation enhancers such as lipid
membranes [7,8], anionic surfactants [9,10] and polyanions
[11–13]. Many species of solutes in physiological media, some
being ionic and others being non-polar, could always coexist at
any sites of the living body. This consideration had led us toAbbreviations: IAPP, human islet amyloid polypeptide; ThT, thioﬂavin
T; HFIP, 1,1,1,3,3,3-hexaﬂuoroisopropanol; TFE, 2,2,2-triﬂuoroet-
hano; iPrOH, isopronanol; EtOH, ethanol; polyE, poly-L-glutamate;
TEM, transmission electron microscopy; GAG, glycosaminoglycan
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stantial roles in the amyloidgenesis. In fact, the ﬁbrillar depos-
its in apoptotic tissues often comprise glycosaminoglycans
(GAGs), lipids, lipo-proteins and other organic molecules
[3,4,13,14].
To support our proposition above, experiments were con-
ducted in vitro for demonstrating a synergistic action of poly-
anionic and non-polar cofactors upon amyloid ﬁbril formation
of IAPP. Deposition of IAPP amyloid in human pancreatic
islet is a common pathological feature of type 2 diabetes
[3,14]. Each of polyanion and non-polar media is known to
promote the IAPP ﬁbrillation [14,15]. Heparin and alcohol
were used for polyanion and non-polar cofactors, respectively.
Heparin is a member of GAGs, abundant in the extracellular
space of the living body, whereas alcohol is the most popular
membrane mimicking solvent and is also known for enhancers
of amyloidgenesis [16]. The aggregation process of IAPP was
monitored by thioﬂavin T (ThT) binding, light scattering and
transmission electron microscopy (TEM). The concentration
of IAPP used here is lower than that of previous studies.2. Materials and methods
Human IAPP was purchased from Peptide Institute Inc. (Osaka,
Japan), and was disaggregated by a method of O’Nuallain and Wetzel
[17]. Peptide solutions contained 20 mM Tris–HCl (pH 7.5), 0.1 M
NaCl, 5 lM ThT, polyanion and alcohol. ThT, heparin, N-acetylhep-
arin, poly-L-glutamate (polyE), 1,1,1,3,3,3-hexaﬂuoroisopropanol
(HFIP) and 2,2,2-triﬂuoroethanol (TFE) were purchased from Sigma
Co. Other chemicals of reagent grade were purchased from Nacalai
Tesque Co. (Kyoto, Japan).
Aggregation process was monitored by light scattering and ThT
ﬂuorescence. The sample solution was prepared in a quartz ﬂuores-
cence cell (3 · 3 mm), sealed with paraﬁlm, and kept at 8 C. The cell
was then transferred to a cell folder of a ﬂuorescence spectrometer F-
2500 (Hitachi, Japan). The cell folder was kept at 37 C by a circulat-
ing water bath. Excitation/emission wavelengths and bandwidths were
340/340 nm and 2/2 nm for light scattering, and 440/480 nm and 5/
10 nm for ThT ﬂuorescence. The kinetic trace of the IAPP aggregation
was ﬁtted by a pseudo-ﬁrst order function [18]:
F ¼ F 0 þ DF
1þ exp½ðt  uÞ=s ð1Þ
where F0 and F are ﬂuorescence intensities at time zero and t. Fitting
parameters are DF, u and s. An initial delay time (td) and an aggrega-
tion rate in the evolution phase (kagg) were determined by kagg = 1/s
and td = u  2 Æ s.
Morphology of aggregates was observed using an H-7000 electron
microscope (Hitachi, Japan), operated at 75 kV. The sample solution
was applied onto a carbon grid and stained with 2% uranyl acetate.
Images were recorded on FG electron-microscopic ﬁlms (Fuji ﬁlm,
Japan), developed in D-19 (Kodak, USA) for 3 min.blished by Elsevier B.V. All rights reserved.
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3.1. IAPP ﬁbrillation in heparin and TFE solutions
Amyloid formation of IAPP was monitored by ThT ﬂuores-
cence in solutions containing heparin and alcohol. The concen-
tration of IAPP was 0.5 lM throughout. At this low peptide
concentration, no aggregate was generated without cofactors
even after incubation for 2 weeks. Typical aggregation kinetic
curves were obtained at 4–8% TFE and 0.5–5 lg/ml heparin
(Fig. 1A), which exhibited an initial delay followed by evolu-
tion and ﬁnal plateau phases. Comparison of the kinetic proﬁle
of ThT ﬂuorescence with that of normal-angle light scattering
showed that the ﬂuorescence intensity was a faithful measure
of the amount of IAPP aggregates (Fig. 1B). Aggregates gen-
erated in these conditions were ﬁbrous in shape (Fig. 1C), typ-
ical for amyloid.
Typical amyloid formation exhibits a nucleation-dependent
kinetic property [19]. The initial aggregation delay observed
in our case is a good indication of this kinetic type
(Fig. 1A). To conﬁrm it further, a seeding experiment was per-
formed (Fig. 1D). Addition of the amyloid seeds to a freshly
prepared sample signiﬁcantly shortened the initial delay time,
supporting that the aggregation of IAPP in the heparin–alco-
hol mixture proceeded in a nucleation-dependent fashion.Fig. 1. IAPP aggregation in heparin-TFE mixtures. (A) Aggregation
monitored by ThT ﬂuorescence. IAPP at 0.5 lM was incubated at
37 C in 20 mM Tris–HCl (pH 7.5), 0.1 M NaCl and 5 lM ThT. Solid
lines: [heparin] = 5 lg/ml and [TFE] = 0%, 4%, 5% or 8% (w/v). A
broken line: [heparin] = 0.5 lg/ml and [TFE] = 5 %. (B) Aggregation
monitored by ThT ﬂuorescence (broken lines) and light scattering (thin
solid lines). [heparin] = 5 lg/ml and [TFE] = 4% or 6% (w/v). (C) A
TEM image of IAPP aggregates formed in 5% TFE and 5 lg/ml
heparin incubated for 2 h. (D) A seeding eﬀect on the IAPP
aggregation kinetics. A reference run without seeds was done with
0.5 lM IAPP, 5% TFE and 5 lg/ml heparin (a broken line). A seeded
run (a solid line) was done in the same condition as that of the
reference run except that seeds of ﬁbrils are added. The sample
solution after the reference run for 2 h was used as the seeds. The seed
volume was 1/20 of the total volume.3.2. Synergistic action of heparin and TFE
Three kinetic parameters were determined from the aggrega-
tion kinetic proﬁle. Those are an initial delay time (td), an
aggregation rate in the evolution phase (kagg) and a total ﬂuo-
rescence change (DF). All the parameters were changed as a
function of [TFE] and [heparin] (Fig. 2). For example, by
increasing heparin concentration under a ﬁxed TFE concentra-
tion, td was shortened, kagg was accelerated, and DF was in-
creased.
Notably, without TFE, heparin even at 100 lg/ml could not
induce the ﬁbrillation (asterisks of Fig. 2A: incubation for one
week), whereas 0.5 lg/ml or less of heparin was enough to
form ﬁbrils in the presence of TFE (open circles of Fig. 2A).
Similarly, TFE was ineﬀective up to 15% in the absence of hep-
arin, whereas 5% or less of TFE induced the IAPP aggregation
with a trace amount of heparin (Fig. 2B). These results indicate
that the aggregation enhancement in the heparin-TFE mixture
cannot be explained by a simple sum of the two independent
cofactor’s actions. The coexistence eﬀect of the two is non-lin-
early strong. We do not assert that the synergistic eﬀect is al-
ways required for the IAPP aggregation at higher IAPP
concentration or at higher cofactors concentrations than those
we tested here. Our conclusion was stated within this limit. InFig. 2. Kinetic parameters for the IAPP ﬁbrillation monitored by ThT
ﬂuorescence. Experimental conditions were the same as those of
Fig. 1A. Each kinetic trace was ﬁtted by Eq. (1). (A) DF for 0%
(asterisks) or 5% TFE (circles) at various heparin concentrations. A log
scale was used for the horizontal axis. (B) DF for 0 lg/ml (asterisks) or
5 lg/ml heparin (circles) at various TFE concentrations. To obtain the
DF values for the asterisks in (A) and (B), the sample solutions were
incubated at 37 C for one week. (C) td (open circles) and kagg (ﬁlled
circles) for 5% TFE at various heparin concentrations. (D) td (open
circles) and kagg (ﬁlled circles) for 5 lg/ml heparin at various TFE.
Data points of (A)–(D) are given by averaging three or four
independent experiments. Error bars are the standard deviations.
Fig. 4. IAPP aggregation induced by various polyanion species. IAPP
of 0.5 lMwere incubated at 37 C in 20 mM Tris–HCl (pH 7.5), 0.1 M
NaCl, 5 lM ThT and 6% TFE. (A) Aggregation kinetics monitored by
ThT ﬂuorescence in the presence of 5 lg/ml heparin (trace 1), 50 lg/ml
N-acetylheparin (trace 2) or 200 lg/ml polyE (trace 3). (B) A TEM
image of IAPP aggregates induced by 200 lg/ml polyE and 6% TFE,
incubated at 37 C for 2.5 h.
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enhance the IAPP ﬁbrillation at higher peptide concentrations
[11,20].
3.3. Eﬀects of other alcohol and polyanion species
A variety of alcohol species could cooperate with heparin in
the IAPP ﬁbrillation (Fig. 3). In the presence of 5 lg/ml hepa-
rin, HFIP induced the ﬁbrillation at less than 1 % (Fig. 3A). In
case of isopropanol (iPrOH) or ethanol (EtOH), higher alcohol
concentrations are required for the ﬁbrillation (Fig. 3B). The
order of the eﬃciency was HFIP > TFE > iPrOH > EtOH
(Fig. 3C). We also tested the eﬀects of other polyanion species,
N-acetylheparin and polyE, which could also yield the IAPP
ﬁbrils only when the solution contained TFE (Fig. 4).
3.4. Possible mechanisms of the synergistic actions
Possible mechanisms of the synergistic eﬀect of polyanion
and alcohol could be as follows. Alcohol at low concentrations
reduces backbone solubility of polypeptide chain and stabilizes
hydrogen bonds between peptide components [21]. Polyanion
attracts basic amino acid residues and condensates polypeptide
chains at the polyanionic sites [11,12]. The alcohol-driven
hydrogen bonding within a polypeptide chain combined with
the polyanion-mediated neutralization of the intra-chain elec-
trostatic repulsion could generate a compact polypeptide con-
formation prone to amyloid-type assembly. This mechanistic
interpretation of our results is consistent with a ﬁnding byFig. 3. IAPP aggregation induced by various alcohol species. IAPP of
0.5 lM were incubated at 37 C in 20 mM Tris–HCl (pH 7.5), 0.1 M
NaCl, 5 lM ThT and 5 lg/ml heparin. Aggregation kinetics was
monitored by ThT ﬂuorescence. Kinetic traces in the presence of 0.5%,
1% or 1.5% HFIP (A) or of 10% iPrOH or 10% EtOH (B). In panel
(C), DF values are plotted against the concentration of HFIP (ﬁlled
circles), TFE (open circles), iPrOH (asterisks) or EtOH (triangles).Munishkina et al. [16] that the partially folded compact con-
formation induced by relatively low concentrations of alcohols
enhances the ﬁbril formation of a-synuclein. Alternatively,
well-ordered amyloid-type assembly of the peptide could also
be directed by regular arrangement of the polypeptide chains
at the regularly spaced polyanionic sites, where the alcohol ef-
fect could further reﬁne and stabilize this peptide assembly by
forming inter-molecular hydrogen bonding.
We would also mention recent theoretical studies by Kinosh-
ita and his colleagues, which proposed that translational entro-
py gain of solvents is a primary driving force for the amyloid-
type protein assembly [22]. This theory claims that a mixture of
water and solute molecules with a variety of molecular sizes
can maximize the translational entropy gain accompanied with
the ordered protein assembly [23]. This mechanism of entropic
origin might also contribute for the enhancement of the amy-
loidgenesis in the media comprising a variety of molecular spe-
cies as observed in the present study.
3.5. Biological implications
Polyanionic molecules such as GAGs and nucleic acids are
abundant in human tissues, and have been suggested to pro-
mote amyloidgenesis [3,14,15,20]. However, the eﬀects of
polyanions must be weak in physiological media containing
counter cations. The weakened polyanionic eﬀects in vivo
may require synergistic action with the non-polar milieu for
promoting the amyloidgenesis. On the other hand, a surface
of biomembrane is a plausible site of amyloid nucleation
[3,7,8,24], where negative charges at head group of lipid mole-
cules are essential for the ﬁbril formation [10,25]. It means that
co-existence of anionic and non-polar parts of the lipid mem-
brane is essential. These considerations agree well with the
present observations in the polyanion–alcohol mixtures.
Strong synergistic action of multiple cofactors might play
important roles in amyloidgenesis in the living body.
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